Kadoya Ken, Tsukada Shingo, Lu Paul, Coppola Giovanni, Geschwind Dan, Filbin Marie T, Blesch Armin, Tuszynski Mark H
Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
Neuron. 2009 Oct 29;64(2):165-72. doi: 10.1016/j.neuron.2009.09.016.
Despite advances in promoting axonal regeneration after acute spinal cord injury (SCI), elicitation of bridging axon regeneration after chronic SCI remains a formidable challenge. We report that combinatorial therapies administered 6 weeks, and as long as 15 months, after SCI promote axonal regeneration into and beyond a midcervical lesion site. Provision of peripheral nerve conditioning lesions, grafts of marrow stromal cells, and establishment of NT-3 gradients supports bridging regeneration. Controls receiving partial components of the full combination fail to exhibit bridging. Notably, intraneuronal molecular mechanisms recruited by delayed therapies mirror those of acute injury, including activation of transcriptional activators and regeneration-associated genes. Collectively, these findings provide evidence that regeneration is achievable at unprecedented postinjury time points.
尽管在促进急性脊髓损伤(SCI)后轴突再生方面取得了进展,但引发慢性SCI后的桥接轴突再生仍然是一项艰巨的挑战。我们报告称,在SCI后6周以及长达15个月给予的联合疗法可促进轴突再生进入并越过颈中部损伤部位。提供周围神经预处理损伤、骨髓基质细胞移植以及建立NT-3梯度可支持桥接再生。接受完整联合疗法部分成分的对照组未表现出桥接现象。值得注意的是,延迟疗法所募集的神经元内分子机制与急性损伤时的机制相似,包括转录激活因子和再生相关基因的激活。总体而言,这些发现提供了证据,表明在损伤后前所未有的时间点实现再生是可行的。